Sex reporting of cells used in cancer research: A systematic review

Sex and gender disparities in biomedical research have been emphasized to improve scientific knowledge applied for the health of both men and women. Despite sex differences in cancer incidence, prognosis, and responses to therapeutic agents, mechanistic explanations at molecular levels are far from...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The FASEB journal 2024-03, Vol.38 (6), p.e23552-n/a
Hauptverfasser: Park, Mi‐Na, Kim, Sung‐Eun, Choi, Sungin, Chang, Yoomee, Kim, Hyeyoon, Lee, Ha‐Eun, Lee, Suk Kyeong, Sung, Mi‐Kyung, Paik, Hee‐Young
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Sex and gender disparities in biomedical research have been emphasized to improve scientific knowledge applied for the health of both men and women. Despite sex differences in cancer incidence, prognosis, and responses to therapeutic agents, mechanistic explanations at molecular levels are far from enough. Recent studies suggested that cell sex is an important biological variable due to differences in sex chromosome gene expression and differences in events associated with developmental biology. The objective of this study was to analyze the reporting of sex of cells used in cancer research using articles published in Cancer Cell, Molecular Cancer, Journal of Hematology & Oncology, Journal for ImmunoTherapy of Cancer, and Cancer Research in 2020, and to examine whether there exists any sex bias. We found that the percentage of cells with sex notation in the article was 36.5%. Primary cells exhibited higher sex notation compared to cell lines. A higher percentage of female cells were used in cell cultures with sex notation. Also, sex‐common cells omitted sex description more often compared to sex‐specific cells. None of the cells isolated from embryo and esophagus reported the cell sex in the article. Our results indicate cell sex report in cancer research is limited to a small proportion of cells used in the study. These results call for acknowledging the sex of cells to increase the applicability of biomedical research discoveries. Cell sex is an important biological variable due to variations in sex chromosome gene expression and developmental biology events. This review underlines inadequate reporting of cell sex origin in vitro studies published in high‐impact oncology journals in 2020. Considering growing evidence of sex‐specific disparities in cancer biology and treatment, our results highlight the importance of disclosing cell sex in preclinical and clinical studies. This practice is essential for a better understanding and the successful application of biomedical research discoveries (Created with BioRender.com).
ISSN:0892-6638
1530-6860
DOI:10.1096/fj.202301986R